Keywords: prostatic neoplasms; watchful waiting; biopsy; prostate-specific antigen; disease progressionAS, active surveillance; PSA, prostate specific antigen; PSAD, PSA density; RP, radical prostatectomy
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: prostatic neoplasms; prostate-specific antigen; mass screening; African Americans; AfricaDRE, digital rectal examination; fPSA, free PSA; PSA, prostate specific antigen; PSAD, PSA density; TRUS, transrectal ultrasound
Keywords: prostate; prostatic neoplasms; African Americans; risk; neoplasm gradingAA, black; AS, active surveillance; BMI, body mass index; GS, Gleason score; MRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; PSAD, PSA density;
Keywords: prostate; prostatic neoplasms; prostate-specific antigen; biopsy; riskAS, active surveillance; NPV, negative predictive value; PPV, positive predictive value; PSA, prostate specific antigen; PSAD, PSA density; PSAV, PSA velocity; RC, risk count
Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes
Keywords: watchful waiting; neoplasm grading; disease progression; prostatic neoplasmsAS, active surveillance; BXn, biopsy number after initial upgrade; GS, Gleason score; PCa, prostate cancer; PSA, prostate specific antigen; PSAD, PSA density; PSM, positive surgic
Expanded Criteria to Identify Men Eligible for Active Surveillance of Low Risk Prostate Cancer at Johns Hopkins: A Preliminary Analysis
Keywords: prostate; prostatic neoplasms; prostatectomy; prostate-specific antigen; riskAS, active surveillance; BCR, biochemical recurrence; PSA, prostate specific antigen; PSAd, PSA density; RP, radical prostatectomy
Risk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active Surveillance
Keywords: prostate; prostatic neoplasms; prostate-specific antigen; biopsy; riskAS, active surveillance; PSA, prostate specific antigen; PSAD, PSA density; PSAV, PSA velocity; RP, radical prostatectomy
Risk Stratification of Men Choosing Surveillance for Low Risk Prostate Cancer
Keywords: prostate; prostatic neoplasms; biopsy; prostate specific antigen; disease progressionfPSA, free PSA; PSA, prostate specific antigen; PSAD, PSA density
Eligibility for Active Surveillance and Pathological Outcomes for Men Undergoing Radical Prostatectomy in a Large, Community Based Cohort
Keywords: prostate; prostatic neoplasms; neoplasm recurrence; prostatectomy; clinical protocolsAS, active surveillance; BR, biochemical recurrence; JH, Johns Hopkins; PSA, prostate specific antigen; PSAD, PSA density; RP, radical prostatectomy; UCSF, University of
The Performance of Prostate Specific Antigen, Prostate Specific Antigen Density and Transition Zone Density in the Era of Extended Biopsy Schemes
Keywords: prostate; prostatic neoplasms; prostate-specific antigen; biopsy; diagnosisBPH, benign prostatic hyperplasia; DRE, digital rectal examination; NML, normal; PSA, prostate specific antigen; PSAD, PSA density; PSAD-TZ, transition zone density; TRUS, transrec
Racial Variations in the Performance of Prostate Specific Antigen and Prostate Specific Antigen Density in the Era of Extended Prostate Biopsy Schemes
Keywords: prostate; prostatic neoplasms; prostate-specific antigen; biopsy; continental population groupsBPH, benign prostatic hyperplasia; DRE, digital rectal examination; PSA, prostate specific antigen; PSAD, PSA density; PSAD-TZ, transition zone PSAD
Expectant Management of Prostate Cancer With Curative Intent: An Update of The Johns Hopkins Experience
Keywords: prostate; prostatic neoplasms; follow-up studies; age factorsPSA, prostate specific antigen; PSAD, PSA density; PSADT, PSA doubling time; PSAV, PSA velocity